SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ANGO

Angiodynamics Inc (NASDAQ:ANGO)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$10.81+$0.05 (+0.46%)
 
Market cap
$455M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 1, 2004
Market Cap$454.61M-9.5%
Revenue (ttm)$325.38M+8.2%
Net Income-$32.94M-2.6%
EPS-$0.79-1.3%
Shares Out42.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume430,343
Open$10.54
Previous Close$10.76
Day's Range$10.53 - $11.00
52-Week Range$9.39 - $16.29
Beta0.28
AnalystsHold
Price Target$19.00(+75.76%)
Earnings DateJan 6, 2027

About ANGO

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.

Address
14 Plaza Drive, Latham, NY, 12110, US
Market Cap
455 million
Employees
632
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$654.69K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
2 Buy0 Hold0 SellAvg target $18.00 (+66.5%)

2 firms rating ANGO in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From ANGO’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.46%
5 Days
-9.62%
1 Month
-9.08%
6 Months
-9.62%
1 Year
-9.54%

$ANGO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ANGO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ANGO's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ANGO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ANGO Revenue by Segment or Geography

$80.92MTotal
Med Device$41.00M50.67%
Med Tech$39.92M49.33%

As of: Q3 2026 (Aug 31, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New ANGO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ANGO from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ANGO

VTIVanguard Morningstar Total Stock Market ETF$12.51M
IWMiShares Russell 2000 ETF$10.38M
VXFVanguard Extended Market ETF$5.18M
DFASDimensional - US Small Cap ETF$3.37M
IWNiShares Russell 2000 Value ETF$2.91M
VTWOVanguard Russell 2000 ETF$2.62M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ANGO’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
3
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

TYNEDirexion Nanotechnology ETF2.60%
XHEState Street SPDR S&P Health Care Equipment ETF0.53%
QQQSInvesco NASDAQ Future Gen 200 ETF0.44%
FESCFirst Eagle Small Cap Equity ETF0.33%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.31%
FVIFirst Trust Total US Market AlphaDEX ETF0.21%
LNGRGlobal X Aging Population ETF0.21%
PQSVPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF0.14%
DMRSDeltaShares S&P 600 Managed Risk ETF0.13%
SYZLazard US Systematic Small Cap Equity ETF0.12%
IWCiShares Micro-Cap ETF0.11%
SMLVState Street SPDR US Small Cap Low Volatility Index ETF0.10%

Weight is the stock’s share of each fund’s holdings.